论文部分内容阅读
1文献类型治疗。2证据水平1b。3文献来源Herbst RS,Johnson DH,Mininberg E,et al.PhaseⅠ/Ⅱtrial evaluating the anti-vascularendothelial growth factor monoclonal antibodyBevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase